CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

NCT06237816 | Recruiting DMC

• 1 other identifier: Okado-2023-2
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.

Conditions

Cancer; Oncology

Outcome Measures

Primary Outcomes (1)

• Change in patients' awareness and knowledge of clinical trials

  Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials.

  18 months

Study Arms (2)

Patient Education Intervention

EXPERIMENTAL

A multimedia educational series is designed to provide patient education on cancer clinical trials. The following topics are addressed: * What is a clinical trial? * Types of clinical trials. * Phases of clinical trials. * Benefits and drawbacks. * Costs. * FAQs. This section covers common myths and clarifies these myths using a Q\&A format. * How to join a clinical trial. Information about eligibility and informed consent. * Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient. The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation.

Other: Patient Education Intervention

Provider Education Intervention

EXPERIMENTAL

The provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability. Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes: * An overview of clinical trials infrastructure in Hawaii. * Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider. * An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions.

Other: Provider Education Intervention

Interventions

Patient Education Intervention OTHER

Multimedia Educational Videos

Patient Education Intervention

Provider Education Intervention OTHER

Provider workshops via zoom

Provider Education Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients must have been diagnosed with any cancer.
• Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
• Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.
• Patients must be residents of Hawaii, Kauai, or Maui counties.

You may not qualify if:

• Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.

Sponsors & Collaborators

• University of Hawaii: lead
• Agency for Healthcare Research and Quality (AHRQ): collaborator

Study Sites (1)

Univesity of Hawaii Cancer Center

Honolulu, Hawaii, 96813, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Izumi Okado, PhD

  University of Hawaii Cancer Research Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Izumi Okado, PhD

CONTACT

(808) 564-5978; iokado@cc.hawaii.edu

Aaron Roberts

CONTACT

8084404583; aroberts@cc.hawaii.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 7, 2023
• First Posted: February 2, 2024
• Study Start: May 1, 2025
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): December 1, 2026
• Last Updated: November 6, 2025

Record last verified: 2025-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)